Publications

Year of Publication Title Faculty Association
2016 Cyclic non-opioid dynorphin A analogues for the bradykinin receptors. Frank Porreca, PhD
2016 Highlights From the AM Assoc of Pharmaceutical Scientists/International Transporter Consortium Joint Workshop on Drug Transporters in Absorption, Distribution, Metabolism, and Excretion: From the Bench to the Bedside - Clinical Pharmacology Considerations Patrick T Ronaldson, PhD, FAAPS
2016 The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain. Tally Largent-Milnes, PhD, Patrick W Mantyh, Todd Vanderah, PhD
2016 Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative. Roberta Diaz Brinton, Ph.D
2016 Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1.
2016 Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention. Roberta Diaz Brinton, Ph.D
2016 (S)-Lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. Frank Porreca, PhD, Todd Vanderah, PhD
2016 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion. John M. Streicher, PhD
2016 Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2016 Altered brain energetics induces mitochondrial fission arrest in Alzheimer's Disease. Roberta Diaz Brinton, Ph.D
2016 Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2016 Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain. Frank Porreca, PhD
2016 Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling. Nam Lee, Ph.D.
2016 Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2016 Effect of Reproductive History and Exogenous Hormone Use on Cognitive Function in Mid- and Late Life. Roberta Diaz Brinton, Ph.D
2016 Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery. Jeffrey J. Lochhead, PhD
2016 Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype. Roberta Diaz Brinton, Ph.D
2016 Biphalin: The Foundation of Bivalent Ligands.
2016 Regulation of gene expression and mitochondrial dynamics by SMAD. Nam Lee, Ph.D.
2016 Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment.
2016 Dynorphin A analogs for the treatment of chronic neuropathic pain.
2016 Cyclic Opioid Peptides.
2016 Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex. Roberta Diaz Brinton, Ph.D
2015 Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. Roberta Diaz Brinton, Ph.D
2015 Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD

Pages